Nuclear Receptors and Transcription Factors in Obesity-Related Kidney Disease
Authors:
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Seminars in Nephrology
- Vol. 41 (4) , 318-330
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK116567, R01 DK127830)
- National Center for Advancing Translational Sciences (TL1 TR001431)
This publication has 144 references indexed in Scilit:
- Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular MechanismsPPAR Research, 2013
- Identification of the vitamin D receptor in various cells of the mouse kidneyKidney International, 2012
- Nuclear receptors in renal diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 AgonistMolecular Pharmacology, 2010
- Transgenic expression of proximal tubule peroxisome proliferator–activated receptor-α in mice confers protection during acute kidney injuryKidney International, 2009
- Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitusNephrology Dialysis Transplantation, 2009
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory responseHepatology, 2008
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increaseProceedings of the National Academy of Sciences of the United States of America, 2008
- Protein Sensors for Membrane SterolsCell, 2006
- Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in ratsKidney International, 2001